Indaptus Therapeutics (INDP) Misses Q1 EPS by 23c

Indaptus Therapeutics (NASDAQ: INDP) reported Q1 EPS of ($0.23).

For earnings history and earnings-related data on Indaptus Therapeutics (INDP) click here.

You May Also Be Interested In

• Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
• Walmart (WMT) PT Lowered to $115 at Wolfe Research
• Wolfe Research sees strong S&P 500 earnings momentum